RISO-KAGAKU-CORPORATION
19.8.2019 08:02:08 CEST | Business Wire | Press release
RISO KAGAKU CORPORATION (President & CEO: Akira Hayama; hereinafter “RISO”) announced today the launch of VALEZUS, a new brand of high-speed ink-jet printers for the production-printing market. RISO will start with successive rollouts worldwide of the new brand’s first product, the VALEZUS T2100, a high-speed, 320-page-per-minute (320-ppm) cut-sheet printer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190818005001/en/
One of RISO’s commanding strengths is the development of inks optimized for high-speed paper feeding and high-speed printing. This expertise enables RISO to deliver unique printing solutions serving the demand for high-volume printing. With technologies developed and cultivated in this field, RISO launches the VALEZUS, a fresh brand targeting the production-printing market.
2 The all-new VALEZUS T2100
VALEZUS T2100
The first product of the new brand, the VALEZUS T2100 is a high-speed full-color cut-sheet inkjet printer. By connecting printer engines to print the front and back-side respectively, the VALEZUS T2100 achieves a blazing-fast double-sided printing speed of 320ppm. The VALEZUS T2100 offers a compact footprint for a production printer as well as superior ease of use and maintenance.
With these features, the VALEZUS T2100 increases productivity and dramatically improves work efficiency in high-volume printing.
In high-volume printing applications, such as transactional printing at print service providers, in-house printing at financial institutions, insurance companies and government offices, the VALEZUS T2100 opens a world of new possibilities in cut-sheet printing.
RISO will show the VALEZUS T2100 at the following exhibitions:
“The Print Show 2019” from September 17 to 19 in Birmingham, United Kingdom.
“PRINTING United 2019” from October 23 to 25 in Dallas, Texas, United States.
You can view a 1-minute promotional video about this product here. https://youtu.be/bpzQLYe1Z54
Product name and launch period
Product name |
VALEZUS T2100 |
Launch period |
Fall 2019 |
Rollout will begin in North America and Europe. Launch dates in Japan and elsewhere in Asia are to be determined.
Main features of the VALEZUS T2100
High Productivity
1) Capable of 320ppm high speed cut sheet printing
The VALEZUS T2100 can print 320ppm*1 or 19,200 pages per hour*2 , based on full-color, double-sided printing of A4-sized paper. Because the VALEZUS T2100 is a cut sheet printer, it can easily handle short-run jobs as well, enabling speedy processing of a diverse range of jobs.
*1 Continuous printing of A4-sized paper with long-edge feed on standard settings
*2 Not including cleaning time
2) Incorporation of newly developed high-capacity feeder/stacker units that enable paper loading/unloading during continuous printing
The VALEZUS T2100 is equipped with two high-capacity feeder/stacker units, each capable of feeding and stacking up to 4,000 sheets (total of 8,000 sheets). The two units can be switched while the printer is active, allowing users to load/unload paper without stopping the job. Also, the stacker unit is equipped with a jogger mechanism and dedicated cart, enabling smooth transition to post-processing after printing.
* The feeder/stacker units are scheduled to be available in the spring of 2020.
3) Compatible with PDF, PostScript® as well as AFP/IPDS
The VALEZUS T2100 can fit in existing workflow of customers. It supports PDF and Postscript, generally used in an open system environment as well as AFP/IPDS, which is used as an industry standard for mission-critical production print applications.
4) Oil-based ink complements environmentally-conscious printing by low energy consumption
The VALEZUS T2100 incorporates an inkjet system that adopts oil-based inks ensuring energy-saving operation. Oil-based inks contribute to energy-saving because there is no need for ink-drying heaters required for water-based inks, and unlike toner-based technologies, there is no heat-fixing process required.
Specifications
ITEM |
Description |
|
Print Type |
Line-type inkjet system (drop on-demand) |
|
Ink Type |
Oil-based pigment ink (Cyan, Magenta, Yellow, Black, Gray) |
|
Print Speed *1 |
Duplex: 320 ppm, Simplex: 160 ppm (A4 LEF, Letter LEF) |
|
Resolution |
Standard |
Black: 600dpi x 600dpi Cyan/Magenta/Yellow/Gray: 300dpi x 300dpi |
Fine |
Black: 600dpi x 600dpi Cyan/Magenta/Yellow/Gray: 300dpi x 600dpi |
|
Paper Size |
Double Tray Feeder |
Max: 330.2mm x 465mm (13” x 18.3”) Min: 148mm x 210mm (5.9” x 8.3”) |
Feed Tray |
Max: 297mm x 432mm (11.6” x 17.0”) Min: 182mm x 210mm (7.2” x 8.3”) |
|
Paper Weight |
Double Tray Feeder |
46gsm to 210gsm (12-lb bond to 56-lb bond) |
Feed Tray |
52gsm to 104gsm (14-lb bond to 28-lb bond) |
|
Paper Tray Capacity |
Double Tray Feeder |
4,000 sheets x 2 trays*2 (Height up to 440mm [17.3”]) |
Feed Tray |
500 sheets x 3 trays*2 (Height up to 56mm [2.2”]) |
|
Output Tray Capacity |
Double Tray Stacker |
4,000 sheets x 2 trays *2 *3 (Height up to 440mm [17.3”]) |
Power Consumption |
Max. 3,010W |
|
Dimensions (W x D x H) |
4,755mm x 750mm x 1,445mm (187.2” x 29.6” x 56.9”) |
|
*1 When using plain paper and recycled paper (85 gsm [23-lb bond]), and standard density setting.
*2 When using plain paper and recycled paper (85 gsm [23-lb bond]).
*3 When short edge is less than 182mm or long edge is less than 257mm, Max capacity is 1,000 sheets.
Specifications are subject to change without notice.
Symbol mark, logo mark and VALEZUS are trademarks or registered trademarks of RISO KAGAKU CORPORATION. Adobe and PostScript are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries. Other corporate names and/or trademarks are either registered trademarks or trademarks of each company, respectively.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190818005001/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
